Latest Insider Transactions at Ge Health Care Technologies Inc. (GEHC)
This section provides a real-time view of insider transactions for Ge Health Care Technologies Inc. (GEHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GE HealthCare Technologies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GE HealthCare Technologies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-7.3%
|
$351,120
$76.68 P/Share
|
|
Sep 11
2025
|
Roland Rott CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
5,341
+7.71%
|
$288,414
$54.71 P/Share
|
|
Sep 01
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,834
-2.06%
|
$133,882
$73.73 P/Share
|
|
Sep 01
2025
|
Philip Rackliffe CEO, AVS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,891
-2.77%
|
$138,043
$73.73 P/Share
|
|
Sep 01
2025
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,897
-2.16%
|
$211,481
$73.73 P/Share
|
|
Sep 01
2025
|
Adam Y Holton Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
464
-2.69%
|
$33,872
$73.73 P/Share
|
|
Sep 01
2025
|
Kenneth R. Stacherski Chief Enterprise Oper. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-1.07%
|
$65,116
$73.73 P/Share
|
|
Sep 01
2025
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,346
-3.22%
|
$828,258
$73.73 P/Share
|
|
Sep 01
2025
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,238
-2.65%
|
$236,374
$73.73 P/Share
|
|
Sep 01
2025
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,079
-2.17%
|
$224,767
$73.73 P/Share
|
|
Aug 15
2025
|
Kenneth R. Stacherski Chief Enterprise Oper. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,217
+19.61%
|
-
|
|
Jun 01
2025
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,712
-13.57%
|
$679,840
$70.54 P/Share
|
|
May 28
2025
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+23.34%
|
-
|
|
May 28
2025
|
Catherine A Lesjak Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
Tomislav Mihaljevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
Anne T Madden Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+16.06%
|
-
|
|
May 28
2025
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+16.06%
|
-
|
|
May 28
2025
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
William J Stromberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,129
+16.27%
|
-
|
|
May 28
2025
|
H Lawrence Culp Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,675
+6.49%
|
-
|
|
May 15
2025
|
Jeannette Bankes CEO, Patient Care Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
37,031
+32.81%
|
-
|
|
Mar 03
2025
|
Thomas J. Westrick CEO, Patient Care Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
3,181
+14.67%
|
-
|
|
Mar 03
2025
|
George A. Newcomb Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+13.05%
|
-
|
|
Mar 03
2025
|
Philip Rackliffe CEO, AVS |
BUY
Grant, award, or other acquisition
|
Direct |
4,916
+21.96%
|
-
|
|
Mar 03
2025
|
Kenneth R. Stacherski Chief Enterprise Oper. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,060
+13.78%
|
-
|
|
Mar 03
2025
|
Kevin Michael O'Neill CEO, PDx |
BUY
Grant, award, or other acquisition
|
Direct |
4,626
+16.76%
|
-
|
|
Mar 03
2025
|
Frank R Jimenez GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,121
+12.39%
|
-
|
|
Mar 03
2025
|
Roland Rott CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
7,952
+20.82%
|
-
|
|
Mar 03
2025
|
James Saccaro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,278
+13.62%
|
-
|
|
Mar 03
2025
|
Adam Y Holton Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,337
+20.11%
|
-
|
|
Mar 03
2025
|
Peter J Arduini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
41,931
+18.96%
|
-
|
|
Mar 03
2025
|
Taha Kass Hout Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,567
+14.49%
|
-
|
|
Mar 01
2025
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-5.46%
|
$158,514
$87.35 P/Share
|
|
Mar 01
2025
|
George A. Newcomb Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
913
-6.31%
|
$79,431
$87.35 P/Share
|
|
Mar 01
2025
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
3,661
-8.69%
|
$318,507
$87.35 P/Share
|
|
Mar 01
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,457
-6.14%
|
$126,759
$87.35 P/Share
|
|
Mar 01
2025
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
34,325
-10.23%
|
$2,986,275
$87.35 P/Share
|
|
Mar 01
2025
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,667
-8.32%
|
$1,015,029
$87.35 P/Share
|
|
Feb 18
2025
|
George A. Newcomb Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,000
-21.14%
|
$184,000
$92.54 P/Share
|
|
Feb 06
2025
|
Peter J Arduini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
67,487
+28.22%
|
-
|
|
Feb 02
2025
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,122
-12.53%
|
$714,736
$88.3 P/Share
|
|
Feb 01
2025
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
934
-1.53%
|
$82,192
$88.3 P/Share
|
|
Feb 01
2025
|
Philip Rackliffe CEO, AVS |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-1.24%
|
$13,904
$88.3 P/Share
|
|
Feb 01
2025
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
979
-1.32%
|
$86,152
$88.3 P/Share
|
|
Feb 01
2025
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-2.1%
|
$32,296
$88.3 P/Share
|
|
Feb 01
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-2.3%
|
$49,104
$88.3 P/Share
|
|
Feb 01
2025
|
George A. Newcomb Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-1.13%
|
$9,504
$88.3 P/Share
|
|
Feb 01
2025
|
Kenneth R. Stacherski Chief Enterprise Oper. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
444
-1.64%
|
$39,072
$88.3 P/Share
|
|
Feb 01
2025
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,206
-2.99%
|
$282,128
$88.3 P/Share
|